A rare and serious cause of pancytopenia in a patient with systemic lupus erythematosus: haemophagocytic lymphohistiocytosis

BMJ Case Rep. 2018 Sep 27:2018:bcr2018226758. doi: 10.1136/bcr-2018-226758.
No abstract available

Keywords: haematology (drugs and medicines); immunology.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Cyclosporine / administration & dosage
  • Cyclosporine / therapeutic use
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use
  • Etoposide / administration & dosage
  • Etoposide / therapeutic use
  • Female
  • Ferritins / blood
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / immunology
  • Lymphohistiocytosis, Hemophagocytic / blood*
  • Lymphohistiocytosis, Hemophagocytic / drug therapy
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Middle Aged
  • Pancytopenia / etiology*
  • Patient Comfort
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents, Phytogenic
  • Immunosuppressive Agents
  • Etoposide
  • Dexamethasone
  • Cyclosporine
  • Ferritins